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Available online 6 July 2016Purpose: The aim of this study was to apply the theory of planned behavior (TPB) with two other factors (action
planning and coping planning) to the medication adherence of adults with epilepsy.
Methods:We measured the elements of the theory of planned behavior (attitude, subjective norm, perceived
behavioral control, and behavioral intention), action planning, and coping planning at baseline among adults
with epilepsy (n= 567, mean± SD age= 38.37 ± 6.71 years, male= 48.5%). Medication adherence wasmea-
sured using the Medication Adherence Report Scale (MARS) and antiepileptic serum level at the 24-month
follow-up. Structural equation modeling (SEM) examined three models relating TPB elements to medication
adherence.
Results: Three SEM models all had satisfactory ﬁt indices. Moreover, attitude, subjective norms, perceived be-
havioral control, and intention together explained more than 50% of the variance for medication adherence
measured using MARS. The explained variance increased to 61.8% when coping planning and action planning
were included in the model, with coping planning having greater association than action planning. In addition,
MARS explained 3 to 5% of the objective serum level.
Conclusion: The theory of planned behavior is useful in understanding medication adherence in adults with
epilepsy, and future interventionsmay beneﬁt by improving such beliefs aswell as beliefs about coping planning.




Theory of planned behavior1. Introduction
The prevalence of epilepsy is high among the neurological disorders
[1,2], with 4 to 10 in every 1000 peopleworldwide and 18 in every 1000
people in Iran diagnosed with the disorder. The issue of epilepsy is par-
ticularly important in developing countries as the incidence rates of
epilepsy (~100 to 190 per 100,000 person-years) are higher than those
in industrialized countries (~40 to 70 per 100,000 person-years) [2].
Fortunately, epileptic seizures can be controlled using antiepileptic
drugs (AEDs): nearly 60% of patients with epilepsy can have seizures
fully controlled by taking prescribed medication [3]. However, medica-
tion nonadherence amongpatientswith epilepsy is between30 and50%
[4–6], and nonadherence results in treatment failure [7]. Studies that
use continuous objective measures of adherence also show high rates
of nonadherence, with less than half of patients taking one-third or
fewer of the prescribed AED doses [8], and only 76% of doses are taken
overall [9]. In addition to reducing control over epileptic seizures, poorealth Research Center (SDH),
lvd., Qazvin 3419759811, Iran.
r@qums.ac.ir (A.H. Pakpour).adherence affects other important health-related outcomes, including
number of hospital admissions, inpatient treatment days, and emergen-
cy room visits; healthcare costs [10,11]; and subjective quality of life
[12]. Therefore, improving medication adherence is a critical issue for
clinicians caring for patients with epilepsy.
Asmedication adherence is a behavioral issue, we hypothesized that
the theory of planned behavior could provide insight into factors that
reduce adherence. The theory of planned behavior was proposed by
Ajzen [13], and it provides a theoretical framework for researchers to
systematically understand the factors that affect behavioral change.
The theory posits that three key elements (attitude, subjective norm,
perceived behavioral control) predict a person's intent to engage in a
behavior such as medication adherence, and behavioral intention, in
turn, predicts behavior. Ajzen [13] deﬁnes attitude as a person's positive
or negative evaluation of performing the behavior, subjective norm as
the perception that other important people approve or disapprove of
the behavior, and perceived behavioral control as a person's views on
his or her capability to do the behavior. Moreover, perceived behavioral
control is thought to predict not only intentions but also directly pre-
dict behavior [14]. As prior research supports the use of the theory
of planned behavior in predicting intention and behavior across differ-
ent populations and behavioral domains [15–17], we propose that the
232 C.-Y. Lin et al. / Epilepsy & Behavior 61 (2016) 231–236theory could also help explain medication adherence among patients
with epilepsy.
In addition to the theory of planned behavior, some studies suggest
that two other factors (action planning and coping planning) predict
people's intentional behavior [18,19]. Action planning refers to speci-
fying the when, where, and how of engaging in a particular behavior,
and once a person has established an intention to engage in a behavior,
action planning is thought to help translate the intention into behavior
[20]. Coping planning refers to anticipating barriers that might come in
the way of enacting a behavior [21]. For example, when patients utilize
coping planning for medication adherence, they consider barriers that
might prevent them from taking medication as well as ways to over-
come those barriers. Moreover, action planning and coping planning
should each mediate the association of intentions on behavior [22,23].
Therefore, the theory of planned behavior, as well as a revision that
adds action planning and coping planning, has been shown to predict
adherence to healthy behavior [24].
In the present study, we explored the factors that associate with
medication adherence in adult patients with epilepsy. In order to assess
the causal effects of intention on medication adherence, we used a
24-month follow-up of adherence behavior. Based on the theory of
planned behavior and the literature on action and coping planning, we
proposed three models to explain the medication adherence. The ﬁrst
model (Model 1, see Fig. 1) is the simplest model, which only adopted
the theory of planned behavior. The behavior measured in Model 1 is
self-report medication adherence, and we hypothesized that attitude,
subjective norm, and perceived behavioral control would associate
with self-reported medication adherence through behavioral intention.
In addition, perceived behavioral control would also directly associate
with self-reported medication adherence. The second model (Model 2,
see Fig. 2) added one index of objectively measured AED serum level
in Model 1. As prior research shows self-reported adherence to be asso-
ciated with objective measures of adherence [25,26], we examined the
extent to which theoretical factors predicted both self-reported and ob-
jectively measured adherence. The third model (Model 3, see Fig. 3)
added action planning and coping planning to Model 2. In addition to
the above hypotheses, Model 3 also hypothesized that behavioral in-
tention would affect medication adherence through action planning
and coping planning and that perceived behavioral control would
relate to medication adherence through action planning and coping
planning.Fig. 1.Model 1: Medicatio2. Methods
2.1. Participants and procedures
The study was performed in ﬁve neurologic clinics in Tehran and
Qazvin from February 2012 through July 2015. The ethics committee
of Qazvin University of Medical Sciences approved the study prior to
participant recruitment.
Patients with epilepsy were invited to participate in this study if
they a) were 18 years old or older, b) were responsible for taking their
own medication, and c) were prescribed AEDs. Patients were excluded
from the study if they a) did not agree to complete informed consent,
b) had intellectual disability, or c) had a progressive medical or neuro-
logical disorder. The participants who agreed to participate ﬁrst signed
awritten informed consent and a background information sheet. Partic-
ipants then completed thequestionnaire for theory of plannedbehavior.
At a 24-month follow-up, participants ﬁlled out theMARS and had their
serum level measured. The reason for measuringMARS and serum level
at a 24-month follow-up is based on the nature of the theory of planned
behavior. The theory of planned behavior claims that an individual
performs a given behavior depending on a combination of particular
individual and social factors, while the presence or absence of these fac-
tors can predict a person's future behavior. Therefore, we need longitu-
dinal evidence when using the theory of planned behavior. Baseline
behavior is considered as past behavior that cannot be viewed as future
behavior. Moreover, according to the recommendations from the devel-
oper, Ajzen, of the theory of planned behavior, past behaviormay not be
a good predictor for future behavior because the past behavior would
represent as a habit [27]. As a result, this study was designed prospec-
tively to assess the behavior of medication adherence at a 24-month
follow-up.
2.2. Instruments
The methods of data collection were questionnaires and a blood
assay. All questionnaires were written in Persian for the Iranian
population.
2.2.1. Medication Adherence Report Scale (MARS)
The MARS is a self-report questionnaire for medication adherence.
We used the brief version of MARS, which contains ﬁve items eachn adherence model.
Fig. 2.Model 2: Medication adherence and serum level model.
233C.-Y. Lin et al. / Epilepsy & Behavior 61 (2016) 231–236rated on a 5-point Likert scale from never (score = 1) to always
(score = 5). The score is summed, and a higher score represents a
higher level of adherence [6]. Moreover, the concurrent validity of the
MARS is supported by signiﬁcant correlations to health personnel scores
(r = 0.50) and serum concentration of medication (r = 0.52) [25].
Although no studies have examined the psychometric properties of
the Persian version of MARS, its linguistic validity is supported by the
employment of a standard translation procedure (forward translation,
back translation, and reconciliation).
2.2.2. Questionnaire for theory of planned behavior
The theory of planned behavior questionnaire included 20 items
which assessed the concepts proposed byAjzen [13]with items adopted
from Pakpour et al. [28]. The questionnaire consists of four parts:
attitude (8 items), subjective norm (3 items), perceived behavioral
control (4 items), and behavioral intention (5 items). Attitude towardFig. 3.Model 3: Medication adherence and serumantiepileptic medication adherence was measured by eight 5-point
evaluative semantic differential scales: “taking medication regularly
as prescribed every day would be: unpleasant–pleasant, good–bad,
harmful–beneﬁcial, wise–foolish, correct–incorrect, unenjoyable–
enjoyable, satisfying–unsatisfying, useful–useless”. The internal consis-
tency for this scale, as assessed using Cronbach'sα, was 0.91. Subjective
norm was measured using the following three items: “People who are
important to me would approve of me taking medication regularly as
prescribed every day”, “I feel under social pressure to take medication
regularly as prescribed every day”, and “It is expected ofme that I should
takemedication regularly as prescribed every day”. All itemsweremea-
sured on a 5-point Likert scale ranging from 1 to 5 with satisfactory
internal consistency (α = 0.90). Perceived behavioral control was
measured using four items (e.g., “For me to take regular medication
in the future is …”), rated on a 5-point Likert scale from 1 (difﬁcult)
to 5 (simple). Behavioral intention was measured using ﬁve itemslevel model with action and coping planning.
Table 1
Participant characteristics (N = 567).
Age (years) (mean ± SD) 38.37 ± 6.71
Education (years) (mean ± SD) 5.81 ± 1.32
Gender (male), n (%) 275 (48.5%)
Employment (yes), n (%) 288 (50.8%)
Married (yes), n (%) 329 (58.0%)
Current smoker (yes), n (%) 78 (13.8%)
Current drinker (yes), n (%) 84 (14.8%)
Body mass index (kg/m2) (mean ± SD) 22.92 ± 4.21
Types of epilepsy, n (%)
Idiopathic generalized epilepsy 164 (28.9%)
Symptomatic partial epilepsy 265 (46.7%)









Age at onset of seizures, years (mean ± SD) 19.21 ± 6.91
Time since diagnosis, years (mean ± SD) 13.38 ± 7.39
Scores on theory of planned behavior (mean ± SD)
Attitude 3.95 ± 0.63
Subjective norm 3.26 ± 0.68
Perceived behavioral control 3.41 ± 1.03
Behavioral intention 3.58 ± 1.06
Action planning (mean ± SD) 2.66 ± 0.82
Coping planning (mean ± SD) 2.53 ± 0.87
Medication adherence measured by MARSa (mean ± SD) 12.81 ± 6.14
Serum levela, n (%)
Below therapeutic range 270 (47.6%)
Within therapeutic range 226 (39.9%)
Above therapeutic range 71 (12.5%)
MARS =Medication Adherence Report Scale.
a Measured at 24-month follow-up.
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5-point Likert scale from 1 (completely disagree) to 5 (completely
agree). All items of perceived behavioral control and behavioral inten-
tion were adopted from Pakpour et al. [28], and both have satisfactory
internal consistency (α = 0.93 for perceived behavioral control and
0.86 for behavioral intention).
2.2.3. Questionnaires for action planning and coping planning
As in Pakpour et al. [28], we used four 5-point Likert scale items
(1= completely disagree, 5= completely agree) reﬂecting action plan-
ning using the stem of “I havemade a detailed plan regarding” to assess
(a) when to, (b) where to, (c) how often to, and (d) how to “take
medication”. Similarly, coping planning was measured using four
5-point Likert scale items (1 = completely disagree, 5 = completely
agree) with the stem of “I have made a detailed plan regarding …”.
The following descriptions for the coping planning were (a) what
to do if something interferes, (b) what to do if I forget it, (c) how tomo-
tivate myself if I do not feel like it, and (d) how to prevent being dis-
tracted. Both action planning and coping planning had satisfactory
internal consistency (α= 0.92 for both).
2.2.4. Objective antiepileptic drug serum level
We used microparticle enzyme immunoassay (MEIA) (Abbott
Axsym®, Abbott Laboratories, Abbott Park, IL, USA) to measure the
AEDdrug concentrations in theplasmaor serum [29]. The blood samples
were derived from the participants before they took the next routine
dose of drugs, and we classiﬁed all patients into three groups (below
the usual therapeutic range, within the usual therapeutic range, and
above the therapeutic range). The group within the usual therapeutic
range is deﬁned as having phenytoin at 10 to 20 mg/l, carbamazepine
at 4 to 10 mg/l, and valproic acid at 50 to 100 mg/l [30].
2.3. Statistical analysis
Descriptive statistics were used to demonstrate the participant
characteristics and their scores on instruments. Structural equation
modeling (SEM) was used to examine three models: the medication
adherence model (Model 1, Fig. 1), the medication adherence and
serum level model (Model 2, Fig. 2), and the medication adherence
and serum level model with action and coping planning (Model 3,
Fig. 3). Model 1 examined whether the theory of planned behavior
can explain the behavior of medication adherence for patients with
epilepsy. Model 2 examined how much the self-report medication ad-
herence measure (MARS) associates with objective AED serum level.
Model 3 examined the mediating roles of action planning and coping
planning in predicting adherence.
We used a maximum likelihood (ML) estimator on Model 1 and a
diagonally weighted least squares (DWLS) estimator on Models 2 and
3 because the latter two models contain a categorical outcome variable
(i.e., serum level). Moreover, we used a series of ﬁt indices to determine
an acceptable model. For both ML and DWLS estimators, acceptable
ﬁt was based on comparative ﬁt index (CFI), a Tucker–Lewis index
(TLI) N0.95, and a root-mean-square error of approximation b0.08
[31,32]. For theML estimator, a standardized root-mean-square residual
(SRMR) b0.08 indicates acceptable ﬁt. For the DWLS estimator, a
weighted root-mean-square residual (WRMR) b0.10 indicates accept-
able ﬁt [33,34].
Descriptive statistics were analyzed using SPSS 17.0, and SEMswere
conducted using the lavaan package [35] in the R software.
3. Results
Approximately 600 patients were invited to participate in the study.
Twenty-three patients were not eligible to be included in the study,
and 10 patients did not agree to participate, resulting in a response
rate of 94.5%.3.1. Descriptive results
The mean age (SD) of the participants (n = 567) was 38.37 years
(6.71); BMI was 22.92 kg/m2 (4.21); educational year was 5.81 years
(1.32). Approximately half of the participants were male (48.5%) and
were employed (50.8%), and slightly more than half of the participants
were married (58.0%). Less than one-ﬁfth of the participants were cur-
rent smokers (13.8%) or current drinkers (14.8%). Nearly half of the
participants (46.7%) were diagnosed as having symptomatic partial
epilepsy; most of the participants (61.9%) had monotherapy (Table 1).
Moreover, the scores of the questionnaire for theory of planned behav-
ior, action planning, coping planning, andMARS are reported in Table 1.
At the 24-month follow-up, slightly less than half of the participants had
their AED serum level below the suggested therapeutic range (47.6%).
We note that medication adherence did not differ between those with
monotherapy and those with polytherapy, while controlling for age,
gender, and time since diagnosis; therefore, we did not include therapy
type in any subsequent analyses.
3.2. Structural models
All three models showed acceptable ﬁt. The CFI and TLI were above
0.95, and RMSEA was less than 0.08 in all three models. Model 1
(Fig. 1) had an SRMR = 0.011, Model 2 (Fig. 2) had a WRMR = 0.996,
andModel 3 (Fig. 3) had aWRMR=0.976. All coefﬁcientswere positive
and signiﬁcant in the three models, except for the nonsigniﬁcant effect
of subjective norm on intention (standardized coefﬁcient = 0.026 in
Model 1, 0.031 in Model 2, and 0.045 in Model 3).
Moreover, attitude, subjective norm, and perceived behavioral con-
trol explained a substantial proportion of the variance for behavioral in-
tention from 61.8% (Model 2) to 69.4% (Model 1). Direct and indirect
effects of attitude, subjective norm, perceived behavioral control, and
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ance for medication adherence measured using MARS. The explained
variance increased to 61.8% when coping planning and action planning
were added in Model 3 to explain the variance for medication adher-
ence. The variances of serum level, an objective index for measuring
adherence, explained by the subjective measures onmedication adher-
ence (i.e., MARS), were 3.7% in Model 2 and 4.7% in Model 3.
We found that behavioral intention had more direct effects (R2 =
0.478) on medication adherence than indirect effects (R2 = 0.130
through action planning, R2 = 0.237 through coping planning), though
direct and indirect effects were both signiﬁcant (Table 2).
4. Discussion
To the best of our knowledge, this is the ﬁrst study using the theory
of planned behavior to understand medication adherence in a sample
with epilepsy. Ourmain ﬁndingwas the evidence of the associations be-
tween behavioral intention andmedication adherence. Overall, our pro-
posed models all had satisfactory ﬁt indices and indicated that the
theory of planned behavior can be useful in understanding the medica-
tion adherence of patients with epilepsy.
However, contrary to the theory of planned behavior's propositions,
our results showed that subjective normhad no associationwith behav-
ioral intention. Consequently, subjective norm had no association with
medication adherence for patients with epilepsy. Despite the ﬁnding
that subjective norm is an important predictor of medication adherence
amongpeoplewith schizophrenia [36], reviews of the theory of planned
behavior generally show that subjective norm has a relatively weak as-
sociation with intention and behavior [15,37]. In the context of this
study, attitudes and perceived behavioral control were both relatively
high, so patients generally felt positively about their medication and
felt control over taking it. Given these positive beliefs, it is possible
that the association between subjective norms and medication adher-
ence was diminished given that other beliefs also supported intentions
towardmedication adherence [38,39]. Nevertheless, our results showed
that behavioral intention is important for a patient with epilepsy to ad-
here to prescribed medication, including its direct effect (R2 = 0.478)
and indirect effects (R2= 0.367). This ﬁnding is comparable to Pakpour
et al.'s [28] ﬁnding that intentions strongly predictedmedication adher-
ence among patients undergoing coronary artery bypass graft (CABG)
surgery. In addition, patients with heart failure withmore favorable be-
liefs about medication adhere better to the prescribed medications and
consequently had a longer event-free survival time [40]. The present
ﬁndings also corroborate prior ﬁndings regarding the theory of planned
behavior: attitude and perceived behavioral control were related to be-
havior via either direct or indirect pathways. Additionally, motivational
interviewing, one type of intervention developed to increase behavioral
intention, has been developed to improve medication adherence [41],
and the effects on patients with epilepsy have also been shown [6].
Coping planning and action planning, as expected, had mediating
roles between intention and behavior. Moreover, our results show
that coping planning (coefﬁcient = 0.281) had a stronger relationship
with medication adherence than action planning (coefﬁcient =Table 2
Direct and indirect effects of behavioral intention on the Medication Adherence Report
Scale (MARS).
Coefﬁcient (SE) p-Value R2
Direct effect 4.00 (0.18) b0.001 0.478
Indirect effect through action planning – – 0.130
Behavioral intention on action planning 0.45 (0.03) b0.001 0.338
Action planning on MARS 4.67 (0.25) b0.001 0.384
Indirect effect through coping planning – – 0.237
Behavioral intention on coping planning 0.55 (0.03) b0.001 0.445
Coping planning on MARS 5.13 (0.20) b0.001 0.532
SE = standard error.0.120), a pattern that is consistent with previous research on physical
activity [24,42]. The relatively strong association between coping plan-
ning and medication adherence is an important ﬁnding of this study,
as it suggests that patients' lack of anticipating barriers to adherence is
an important but understudied factor that determines their adherence
to prescribedmedications. As such, interventions for improvingmedica-
tion adherence among patients with epilepsymay beneﬁt by encourag-
ing patients to anticipate barriers and consider ways to overcome those
barriers.
There are some limitations in the study. First, although intentions
and adherence were measured at different timepoints, the associations
of attitude, subjective norm, and perceived behavioral control with in-
tentionwere based on correlational data, and so, causality cannot be de-
termined. However, the causal relationships among the variables have
strong theoretical justiﬁcation [13,27]. Second, anothermajor limitation
is that we were unable to control all possible confounders on medica-
tion adherence in our study design. The medication adherence was
measured at the 24-month follow-up, and we did not use an experi-
mental design; thus, many factors (e.g., life events) that we cannot con-
trol may inﬂuence themedication adherence. Third, the low correlation
between subjective and objective measures of medication adherence
limited the extent to which the elements of the theory of planned be-
havior predicted objectively assessed adherence behavior. Fourth,
given the participants of this study were adults, our results cannot gen-
eralize to younger populations [31]. Lastly, no study has examined the
psychometric properties of all the Persian version questionnaires in
our study. Questionnaires for theory of planned behavior and those
for action planning and coping planning were designed by our team.
Although our data showed that all the questionnaires have acceptable
internal reliability, we cannot ensure their validity and test–retest reli-
ability. However, we maintain that the use of our self-designed ques-
tionnaires is acceptable as Ajzen [13] argues that questionnaires for
theory of planned behavior constructs should be designed for each
study based on each speciﬁc aim or population. As for the MARS, we
only ensured its linguistic validity, and future studies may want to ex-
amine other psychometric properties of the Persian version of MARS.
In conclusion, the theory of planned behavior can help understand
the factors that correlate with medication adherence among patients
with epilepsy. Clinicians may want to design interventions based on
the theory of planned behavior to improve the medication adherence
for patients with epilepsy. Speciﬁcally, interventions could beneﬁt by
enhancing favorable attitudes toward the mediation and beliefs of per-
ceived behavioral control. In addition, as our results indicate the strong
association between coping planning and medication adherence, clini-
cians may want to help patients with epilepsy develop some coping
skills to overcome commonly faced barriers. For example, the patients
may confront the problems of forgetfulness and low motivation for
them to adhere tomedication. Examples of interventions thatmight ad-
dress these problems include the use of shortmessage service to remind
the patients to takemedication or emphasizing beneﬁcial drug effects to
enhance patients' motivation to adhere to medication.Conﬂict of interest
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